Van Herck K - Search Results

1

Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium).

Van der Wielen M, Van Damme P, Van Herck K, Schlegel-Haueter S, Siegrist CA. Van der Wielen M, et al. Among authors: van damme p, van herck k. Vaccine. 2003 Jun 2;21(19-20):2412-7. doi: 10.1016/s0264-410x(03)00062-8. Vaccine. 2003. PMID: 12744872

2

Combined hepatitis A and B vaccine in elderly.

Van Damme P, Van Herck K, Van der Wielen M. Van Damme P, et al. Among authors: van der wielen m, van herck k. Vaccine. 2004 Jan 2;22(3-4):303-4. doi: 10.1016/j.vaccine.2003.08.011. Vaccine. 2004. PMID: 14670309 No abstract available.

3

A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.

Van Damme P, Van Herck K. Van Damme P, et al. Among authors: van herck k. Expert Rev Vaccines. 2004 Jun;3(3):249-67. doi: 10.1586/14760584.3.3.249. Expert Rev Vaccines. 2004. PMID: 15176942 Free article. Review.

4

Prevention of hepatitis A by Havrix: a review.

Van Herck K, Van Damme P. Van Herck K, et al. Among authors: van damme p. Expert Rev Vaccines. 2005 Aug;4(4):459-71. doi: 10.1586/14760584.4.4.459. Expert Rev Vaccines. 2005. PMID: 16117704 Free article. Review.

5

A review of the long-term protection after hepatitis A and B vaccination.

Van Damme P, Van Herck K. Van Damme P, et al. Among authors: van herck k. Travel Med Infect Dis. 2007 Mar;5(2):79-84. doi: 10.1016/j.tmaid.2006.04.004. Epub 2006 Jun 19. Travel Med Infect Dis. 2007. PMID: 17298912 Review.

6

Benefits of early hepatitis B immunization programs for newborns and infants.

Van Herck K, Van Damme P. Van Herck K, et al. Among authors: van damme p. Pediatr Infect Dis J. 2008 Oct;27(10):861-9. doi: 10.1097/INF.0b013e318173966f. Pediatr Infect Dis J. 2008. PMID: 18776823

7

Impact of rotavirus vaccination on laboratory confirmed cases in Belgium.

Hanquet G, Ducoffre G, Vergison A, Neels P, Sabbe M, Van Damme P, Van Herck K. Hanquet G, et al. Among authors: van damme p, van herck k. Vaccine. 2011 Jun 24;29(29-30):4698-703. doi: 10.1016/j.vaccine.2011.04.098. Epub 2011 May 13. Vaccine. 2011. PMID: 21571023

8

Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.

Van Herck K, Jacquet JM, Van Damme P. Van Herck K, et al. Among authors: van damme p. J Med Virol. 2011 Nov;83(11):1885-91. doi: 10.1002/jmv.22200. Epub 2011 Aug 23. J Med Virol. 2011. PMID: 21915861

9

Two decades of hepatitis B vaccination in mentally retarded patients: effectiveness, antibody persistence and duration of immune memory.

Braeckman T, Van Herck K, Jilg W, Bauer T, Van Damme P. Braeckman T, et al. Among authors: van damme p, van herck k. Vaccine. 2012 Jul 6;30(32):4757-61. doi: 10.1016/j.vaccine.2012.05.044. Epub 2012 May 29. Vaccine. 2012. PMID: 22652400

10

Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults.

Hens N, Habteab Ghebretinsae A, Hardt K, Van Damme P, Van Herck K. Hens N, et al. Among authors: van damme p, van herck k. Vaccine. 2014 Mar 14;32(13):1507-13. doi: 10.1016/j.vaccine.2013.10.088. Epub 2014 Feb 7. Vaccine. 2014. PMID: 24508042 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters